Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

Abroad (travel likely)RecruitingPHASE2

Conditions

Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lu Wang, Shenyang, Liaoning, China
Contact: Study coordinator (Yu Cui) · cuiyu.spu@hotmail.com · 862428897491

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT

Ischemic Stroke, Acute

Abroad (travel likely)RecruitingPHASE3

Porto Alegre, Brazil · Botucatu, Brazil

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Ischemic Stroke

Abroad (travel likely)Recruiting

Innsbruck, Austria · Brussels, Belgium

Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Meizhou, China · Luoyang, China

Al Prediction of Sarcopenia Risk in Neurocritical ICU Patients

Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, Epidural Hematoma, Ischemic Stroke, Brain Neoplasms

Abroad (travel likely)Recruiting

Trabzon, Turkey (Türkiye)